Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 127, Issue 2, 2006, Pages 218-221

  Iatrakis, G ^a   Tsionis, C ^b   Adonakis, G ^c   Stoikidou, M ^a   Anthouli Anagnostopoulou, F ^a   Parava, M ^d   Vouxinou, A ^a   Georgopoulos, N A ^c   Kourounis, G ^c  

^a UNIVERSITY OF WEST ATTICA   (Greece)

^b AGIA OLGA HOSPITAL   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Endometrial thickness; Hyperandrogenemia; Hyperinsulinemia; Insulin resistance; PCOS; Transvaginal ultrasound

Indexed keywords

ADULT; ARTICLE; ASSAY; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; FOLLOW UP; HUMAN; HYPERPLASIA; INSULIN RESISTANCE; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RISK; STATISTICAL ANALYSIS; THICKNESS; TRANSVAGINAL ECHOGRAPHY;

EID: 33747043371     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.01.023     Document Type: Article

References (14)

1. Ovalle F., and Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 77 (2002) 1095-1105
2. Acien P., Quereda F., Matallin P., et al. Insulin, androgens and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 72 1 (1999) 32-40
3. Legro R.S., Finegood D., and Dunaif A. A fasting glucose to insulin ration is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 (1998) 2694-2698
4. Akinmokun A., Selby P.L., Ramaiya K., and Alberti K.G. The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabet Med 9 (1992) 432-437
5. Cheung A.P. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol 98 (2001) 325-331
6. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 January (1) (2004) 19-25
7. Dunaif A., Givens J.R., Haseltine F.P., and Merriam G.R. Current issues in endocrinology and metabolism: polycystic ovary syndrome (1992), Blackwell, Boston p. 377-84
8. Sakamoto C. Sonografic criteria of phasic changes in human endometrial tissue. Int J Gynaecol Obstet 23 (1985) 7-12
9. Fujimoto I., Naishigaki M., Hori M., Ichigo S., Itoh T., and Tamaya T. The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects. J Steroid Biochem Mol Biol 50 (1994) 137-143
10. Apparao K.B.C., Lovely L.P., Gui Y., Lininger R.A., and Lessey B.A. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 66 (2002) 297-304
11. Gregorini S.D., Lespi P.J., and Alvarez G.R. Endometrial carcinoma with polycystic ovaries. Report of two cases in women younger than 40 years old. Medicina 57 (1997) 209-212
12. Aksel S., Wentz A.G., and Jones G.S. Anovulatory infertility associated with adenocarcinoma and adenoma hyperplasia of the endometrium. Obstet Gynecol 41 (1974) 143-150
13. Wild R.A. Long-term health consequences of PCOS. Hum Reprod 8 3 (2002) 231-241
14. Hart R., Hickey M., and Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18 (2004) 671-683